4.6 Article

Research gaps in psoriasis: Opportunities for future studies

期刊

出版社

MOSBY-ELSEVIER
DOI: 10.1016/j.jaad.2013.08.042

关键词

adjunctive therapies; biologics; cardiovascular disease; comorbidities in psoriasis; comparative studies; disease severity; environmental factors in the development of psoriasis; future research studies; methotrexate; molecular studies in psoriatic and psoriatic arthritis; pathomechanisms and genetics of psoriasis; phototherapy; psoriasis; psoriasis guidelines; psoriasis treatment; psoriatic arthritis; psychological; research gaps; therapeutic targets; topical therapies

资金

  1. Abbott
  2. Colgene
  3. Eli Lilly
  4. Pfizer
  5. Janssen
  6. Amgen
  7. Genentech
  8. Astellas
  9. Abbvie
  10. Lilly
  11. Norvatis
  12. Genetech
  13. NIH/NIAMS [K24AR064310]
  14. Abbott Lab
  15. Leo Pharma
  16. National Psoriasis Foundation
  17. Aventis Pharmaceuticals
  18. Ortho Pharmaceuticals
  19. Roche Dermatology
  20. 3M
  21. Dermatology Foundation
  22. American Society for Dermatologic Surgery
  23. American Acne Rosacea Society
  24. Medicis
  25. Coria/Healthpoint/Vaeant
  26. Pharmaderm/Nycomed
  27. Galderma
  28. Stiefel/GSK
  29. Abbott Labs
  30. Centocor
  31. Warner-Chilcott
  32. Bristol-Myers Squibb Dermatology
  33. Photomedex
  34. Novartis
  35. Leo/Peplin
  36. Acuderm
  37. Advanced Tissue Sciences
  38. Allergan
  39. Aventis
  40. Bristol-Myers Squibb
  41. Combe
  42. Curatek
  43. Ferndale
  44. Fujisawa
  45. Hermal
  46. Hoffman LaRoche
  47. Genderm
  48. Glaxo Wellcome
  49. Hill
  50. Mayrand
  51. NeoStrata
  52. Neutrogena
  53. Oclassen
  54. Ortho
  55. Person Covey
  56. Proctor Gamble
  57. RJR Nabisco
  58. Schering-Plough
  59. Shelton
  60. SmithKline
  61. Stiefel
  62. United Catalyst
  63. Upjohn
  64. Wolff Systems
  65. Celgene Corporation
  66. Eli Lilly Co
  67. Jassen Ortho Biotech
  68. LEO Pharmaceuticals
  69. Ranbaxy
  70. Celgene
  71. Anacor
  72. Glaxo Smith Kline
  73. Incyte
  74. Maruho
  75. Novo Nordisk
  76. Schering Plough
  77. Sirtris
  78. Vascular Biogenics
  79. Warner Chilcott
  80. Wyeth
  81. Syntrix Biosystems

向作者/读者索取更多资源

Over the past 2 decades, considerable progress has been made to further elucidate the complex pathogenesis of psoriasis, facilitating the development of a new armamentarium of more effective, targeted therapies. Despite these important advances, substantial deficits remain in our understanding of psoriasis and its treatment, necessitating further research in many areas. In the sixth section of the American Academy of Dermatology Psoriasis Guidelines of Care, gaps in research and care were identified. We discuss the most important gaps in research that currently exist and make suggestions for studies that should be performed to address these deficits. These encompass both basic science and clinical research studies, including large, prospective epidemiologic studies to determine the true prevalence and natural history of psoriasis; further molecular studies in patients with psoriatic and psoriatic arthritis to understand the function of psoriasis susceptibility genes and to identify novel therapeutic targets; studies to examine the role of environmental factors in the development of psoriasis; further investigation of the relationship between psoriasis and cardiometabolic disease; studies that examine the role of adjunctive therapies such as psychological interventions in appropriate patient groups; and finally, studies to identify biomarkers of disease severity and treatment response to optimize patient therapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据